Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: A review

Cancer Investigation

Volumn 23, Issue 3, 2005, Pages 240-255

  Moore, Lee E ^a   Wilson, Robin T ^a   Campleman, Sharan L ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PUBLIC HEALTH INSTITUTE   (United States)

Author keywords

Exposures; Genetic susceptibility; Kidney cancer; Review

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FAMILIAL CANCER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; LIFESTYLE; OBESITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW;

CARCINOMA, RENAL CELL; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; LIFE STYLE; OCCUPATIONAL EXPOSURE; RISK FACTORS;

EID: 20044362590     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-200055962     Document Type: Review

References (234)

1. Landis, S.H.; Murray, T.; Bolder, S.; Wingo, P.A. Cancer statistics, 1999. CA Cancer J. Clin. 1999, 49 (1), pp. 1, 8-31.
2. American Cancer Society. Cancer Facts and Figures, 2003; American Cancer Society: Atlanta, GA, 2003.
3. Lynch, C.F.; Cohen, M.B. Urinary system. Cancer 1995, 75 (Suppl. 1), 316-329.
4. Kreiger, N.; Marrett, L.D.; Dodds, L.; Hilditch, S.; Darlington, G.A. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 1993, 4 (2), 101-110.
5. McCredie, M.; Stewart, J.H. Risk factors for kidney cancer in New South Wales. I. Cigarette smoking. Eur. J. Cancer 1992, 28A (12), 2050-2054.
6. Mellemgaard, A.; Engholm, G.; McLaughlin, J.K.; Olsen, J.H. Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors. Int. J. Cancer 1994, 56 (1), 66-71.
7. Yu, M.C.; Mack, T.M.; Hanisch, R.; Cicioni, C.; Henderson, B.E. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J. Natl. Cancer Inst. 1986, 77 (2), 351-356.
8. McCredie, M.; Pommer, W.; McLaughlin, J.K.; Stewart, J.H.; Lindblad, P.; Mandel, J.S.; Mellemgaard, A.; Schlehofer, B.; Niwa, S. International renal-cell cancer study. II. Analgesics. Int. J. Cancer 1995, 60 (3), 345-349.
9. Bretan, P.N., Jr.; Busch, M.P.; Hricak, H.; Williams, R.D. Chronic renal failure: a significant risk factor in the development of acquired renal cysts and renal cell carcinoma. Case reports and review of the literature. Cancer 1986, 57 (9), 1871-1879.
10. McCredie, M.; Stewart, J.H. Risk factors for kidney cancer in New South Wales. IV. Occupation. Br. J. Ind. Med. 1993, 50 (4), 349-354.
11. Mellemgaard, A.; Engholm, G.; McLaughlin, J.K.; Olsen, J.H. Occupational risk factors for renal-cell carcinoma in Denmark. Scand. J. Work, Environ. & Health 1994, 20 (3), 160-165.
12. Linehan, W.M.; Lerman, M.I.; Zbar, B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 1995, 273 (7), 564-570.
13. Schmidt, L.; Duh, P.M.; Chen, F.; Kishida, T.; Glenn, G.; Choyke, P.; Scherer, S.W.; Zhuang, Z.; Lubensky, I.; Dean, M.; Allikmets, R.; Chidambaram, A.; Bergerheim, U.R.; Feltis, J.T.; Casadevall, C.; Zamarron, A.; Bernues, M.; Richard, S.; Lips, C.J.; Walther, M.M.; Tsui, L.C.; Geil, L.; Orcutt, M.L.; Stackhouse, T.; Zbar, B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 1997, 16 (1), 68-73.
14. Weirich, G.; Glenn, G.; Junker, K.; Merino, M.; Storkel, S.; Lubensky, I.; Choyke, P.; Pack, S.; Amin, M.; Walther, M.M.; Linehan, W.M.; Zbar, B. Familial renal oncocytoma: clinicopathological study of 5 families. J. Urol. 1998, 160 (2), 335-340.
15. Pavlovich, C.P.; Walther, M.M.; Eyler, R.A.; Hewitt, S.M.; Zbar, B.; Linehan, W.M.; Merino, M.J. Renal tumors in the Birt-Hogg-Dube syndrome. Am. J. Surg. Pathol. 2002, 26 (12), 1542-1552.
16. Chow, W.H.; Devesa, S.S.; Warren, J.L.; Fraumeni, J.F., Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999, 281 (17), 1628-1631.
17. Mathew, A.; Devesa, S.S.; Fraumeni, J.F., Jr.; Chow, W.H. Global increases in kidney cancer incidence, 1973-1992. Eur. J. Cancer Prev. 2002, 11 (2), 171-178.
18. Ries LAG. SEER Cancer Statistics Review, 1973-1999, National Cancer Institute; NCI: Bethesda, MD, 2002.
19. SEER 9 Registries. Public Use File Submission, NCI, DCCPS, Surveillance Research Program, Cancer Statistics Branch. 2001.
20. SEER 11 Registries. Public Use File Submission, NCI, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2001.
21. Canto, M.T.; Chu, K.C. Annual cancer incidence rates for Hispanics in the United States: surveillance, epidemiology, and end results, 1992-1996. Cancer 2000, 88 (11), 2642-2652.
22. Lanier, A.P.; Alberts, S.R. Kidney and bladder cancer in Inuit 1969-1988. Acta Oncol. 1996, 35 (5), 595-599.
23. Cobb, N.; Paisano, R. Patterns of cancer mortality among Native Americans. Cancer 1998, 83 (11), 2377-2383.
24. Partin, M.R.; Rith-Najarian, S.J.; Slatter, J.S.; Korn, J.E.; Cobb, N.; Soler, J.T. Improving cancer incidence estimates for American Indians in Minnesota. Am. J. Public Health 1999, 89 (11), 1673-1677.
25. Frost, F.; Taylor, V.; Fries, E. Racial misclassification of Native Americans in a surveillance, epidemiology, and end results cancer registry. J. Natl. Cancer Inst. 1992, 84 (12), 957-962.
26. Wynder, E.L.; Mabuchi, K.; Whitmore, W.F., Jr. Epidemiology of adenocarcinoma of the kidney. J. Natl. Cancer Inst. 1974, 53 (6), 1619-1634.
27. McLaughlin, J.K.; Lindblad, P.; Mellemgaard, A.; McCredie, M.; Mandel, J.S.; Schlehofer, B.; Pommer, W.; Adami, H.O. International renal-cell cancer study. I. Tobacco use. Int. J. Cancer 1995, 60 (2), 194-198.
28. McCredie, M.; Ford, J.M.; Stewart, J.H. Risk factors for cancer of the renal parenchyma. Int. J. Cancer 1988, 42 (1), 13-16.
29. Armstrong, B.; Garrod, A.; Doll, R. A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br. J. Cancer 1976, 33 (2), 127-136.
30. Goodman, M.T.; Morgenstern, H.; Wynder, E.L. A case-control study of factors affecting the development of renal cell cancer. Am. J. Epidemiol. 1986, 124 (6), 926-941.
31. Asal, N.R.; Risser, D.R.; Kadamani, S.; Geyer, J.R.; Lee, E.T.; Cherng, N. Risk factors in renal cell carcinoma. I. Methodology, demographics, tobacco, beverage use, and obesity. Cancer Detect. Prev. 1988, 11 (3-6), 359-377.
32. Talamini, R.; Baron, A.E.; Barra, S.; Bidoli, E.; La Vecchia, C.; Negri, E.; Serraino, D.; Franceschi, S. A case-control study of risk factor for renal cell cancer in northern Italy. Cancer Causes Control 1990, 1 (2), 125-131.
33. Benhamou, S.; Lenfant, M.H.; Ory-Paoletti, C.; Flamant, R. Risk factors for renal-cell carcinoma in a French case-control study. Int. J. Cancer 1993, 55 (1), 32-36.
34. Siemiatycki, J.; Krewski, D.; Franco, E.; Kaiserman, M. Associations between cigarette smoking and each of 21 types of cancer: a multi-site case-control study. Int. J. Epidemiol. 1995, 24 (3), 504-514.
35. McLaughlin, J.K.; Mandel, J.S.; Blot, W.J.; Schuman, L.M.; Mehl, E.S.; Fraumeni, J.F., Jr. A population-based case-control study of renal cell carcinoma. J. Natl. Cancer Inst. 1984, 72 (2), 275-284.
36. Benichou, J.; Chow, W.H.; McLaughlin, J.K.; Mandel, J.S.; Fraumeni, J.F., Jr. Population attributable risk of renal cell cancer in Minnesota. Am. J. Epidemiol. 1998, 148 (5), 424-430.
37. Chow, W.H.; Gridley, G.; Fraumeni, J.F., Jr.; Jarvholm, B. Obesity, hypertension, and the risk of kidney cancer in men. N. Engl. J. Med. 2000, 343 (18), 1305-1311.
38. Kumar, A.; Mittal, S.; Buckshee, K.; Farooq, A. Reproductive functions in obese women. Prog. Food Nutr. Sci. 1993, 17 (2), 89-98.
39. Goldfarb, S.; Pugh, T.D. Morphology and anatomic localization of renal microneoplasms and proximal tubule dysplasias induced by four different estrogens in the hamster. Cancer Res. 1990, 50 (1), 113-119.
40. Weisz, J.; Fritz-Wolz, G.; Clawson, G.A.; Benedict, C.M.; Abendroth, C.; Creveling, C.R. Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney: implications for estrogen-induced renal cancer. Carcinogenesis 1998, 19 (7), 1307-1312.
41. Attia, N.; Tamborlane, W.V.; Heptulla, R.; Maggs, D.; Grozman, A.; Sherwin, R.S.; Caprio, S. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J. Clin. Endocrinol. Metab. 1998, 83 (5), 1467-1471.
42. Narayan, S.; Roy, D. Insulin-like growth factor 1 receptors are increased in estrogen-induced kidney tumors. Cancer Res. 1993, 53 (Suppl. 10), 2256-2259.
43. Kasiske, B.L.; O'Donnell, M.P.; Keane, W.F. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 1992, 19 (Suppl. 1), I110-I115.
44. Huang, Z.S.; Chien, K.L.; Yang, C.Y.; Tsai, K.S.; Wang, C.H. Peripheral differential leukocyte counts in humans vary with hyperlipidemia, smoking, and body mass index. Lipids 2001, 36 (3), 237-245.
45. Lindblad, P.; Mellemgaard, A.; Schlehofer, B. International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int. J. Cancer 1995, 61, 192-198.
46. Chow, W.-H.; McLaughlin, J.K.; Mandel, J.S.; Blot, W.J.; Niwa, S.; Fraumeni, J.F., Jr. Reproductive factors and the risk of renal cell cancer among women. Int. J. Cancer 1995, 60, 321-324.
47. Gago-Dominguez, M.; Castelao, J.E.; Yan, J.M.; Ross, R.K.; Yu, M.C. Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol. Biomark. Prev. 1999, 8, 999-1003.
48. Deguchi, J.; Miyamoto, M.; Okada, S. Sex hormone-dependent renal cell carcinogenesis induced by ferric nitrilotriacetate in Wistar rats. Jpn. J. Cancer Res. 1995, 86, 1068-1071.
49. McLaughlin, J.K.; Chow, W.H.; Mandel, J.S.; Mellemgaard, A.; McCredie, M.; Lindblad, P.; Schlehofer, B.; Pommer, W.; Niwa, S.; Adami, H.O. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int. J. Cancer 1995, 63 (2), 216-221.
50. Raynor, W.J., Jr.; Shekelle, R.B.; Rossof, A.M.; Maliza, C.; Paul, O. High blood pressure and 17-year cancer mortality in the Western Electric Health Study. Am. J. Epidemiol. 1981, 113 (4), 371-377.
51. Buck, C.; Donner, A. Cancer incidence in hypertensives. Cancer 1987, 59 (7), 1386-1390.
52. Hole, D.J.; Hawthorne, V.M.; Isles, C.G.; McGhee, S.M.; Robertson, J.W.; Gillis, C.R.; Wapshaw, J.A.; Lever, A.F. Incidence of and mortality from cancer in hypertensive patients. BMJ 1993, 506 (6878), 609-611.
53. McCredie, M.; Stewart, J.H. Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 1992, 3 (4), 323-331.
54. Goldbourt, U.; Holtzman, E.; Yaari, S.; Cohen, L.; Katz, L.; Neufeld, H.N. Elevated systolic blood pressure as a predictor of long-term cancer mortality: analysis by site and histologic subtype in 10,000 middle-aged and elderly men. J. Natl. Cancer Inst. 1986, 77 (1), 63-70.
55. Asal, N.R.; Geyer, J.R.; Risser, D.R.; Lee, E.T.; Kadamani, S.; Cherng, N. N. Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions. Cancer Detect. Prev. 1988, 13 (3-4), 263-279.
56. Chow, W.H.; McLaughlin, J.K.; Mandel, J.S.; Wacholder, S.; Niwa, S.; Fraumeni, J.F., Jr. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension. Cancer Epidemiol. Biomark. Prev. 1995, 4 (4), 327-331.
57. Mellemgaard, A.; Niwa, S.; Mehl, E.S.; Engholm, G.; McLaughlin, J.K.; Olsen, J.H. Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int. J. Epidemiol. 1994, 23 (5), 923-930.
58. McLaughlin, J.K.; Malker, H.S.; Blot, W.J.; Weiner, J.A.; Stone, B.J.; Ericsson, J.L.; Fraumeni, J.F., Jr. Renal cell cancer among architects and allied professionals in Sweden. Am. J. Ind. Med. 1992, 21 (6), 873-876.
59. Shapiro, J.A.; Williams, M.A.; Weiss, N.S.; Stergachis, A.; LaCroix, A.Z.; Barlow, W.E. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am. J. Epidemiol. 1999, 149 (6), 521-530.
60. Federation of American Societies for Experimental Biology, L.S.R.O. Third Report on Nutrition Monitoring in the United States; U.S. Government Printing Office: Washington, D.C., 1995.
61. Chow, W.H.; Devesa, S.S.; Fraumeni, J.F., Jr. Epidemiology of renal cell carcinoma. Part III. Kidney cancers. In Comprehensive Textbook of Genitourinary Oncology; Vogelzang, N.J., Scardino, P.T., Shipley, W.U., Coffey, D.S., Miles, B.J., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, 2000.
62. Flegal, K.M.; Carroll, M.D.; Kuczmarski, R.J.; Johnson, C.L. Overweight and obesity in the United States; prevalence and trends, 1960-1994. Int. J. Obes. Relat. Metab. Disord. 1998, 22 (1), 39-47.
63. Brown, C.D.; Higgins, M.; Donato, K.A.; Rohde, F.C.; Garrison, R.; Obarzanek, E.; Ernst, N.D.; Horan, M. Body mass index and the prevalence of hypertension and dyslipidemia. Obes. Res. 2000, 8 (9), 605-619.
64. Chow, W.H.; McLaughlin, J.K.; Linet, M.S.; Niwa, S.; Mandel, J.S. Use of analgesics and risk of renal cell cancer. Int. J. Cancer 1994, 59 (4), 467-470.
65. Matson, M.A.; Cohen, E.P. Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore) 1990, 69 (4), 217-226.
66. Levine, E.; Slusher, S.L.; Grantham, J.J.; Wetzel, L.H. Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study. AJR Am. J. Roentgenol. 1991, 156 (3), 501-506.
67. Brownson, R.C. A case-control study of renal cell carcinoma in relation to occupation, smoking, and alcohol consumption. Arch. Environ. Health 1988, 43 (3), 238-241.
68. Maclure, M.; Willett, W. A case-control study of diet and risk of renal adenocarcinoma. Epidemiology 1990, 1 (6), 430-440.
69. McLaughlin, J.K.; Gao, Y.T.; Gao, R.N.; Zheng, W.; Ji, B.T.; Blot, W.J.; Fraumeni, J.F., Jr. Risk factors for renal-cell cancer in Shanghai. China. Int. J. Cancer 1992, 52 (4), 562-565.
70. WoIk, A.; Gridley, G.; Niwa, S.; Lindblad, P.; McCredie, M.; Mellemgaard, A.; Mandel, J.S.; Wahrendorf, J.; McLaughlin, J.K.; Adami, H.O. International renal cell cancer study. VII. Role of diet. Int. J. Cancer 1996, 65 (1), 67-73.
71. Lindbland, P.; Wolk, A.; Bergstrom, R.; Adami, H.-O. Diet and risk of renal cell cancer: a population-based case-control study. Cancer Epidemiol. Biomark. Prev. 1997, 6, 215-223.
72. Yuan, J.-M.; Gago-Dominguez, M.; Castelao, J.E.; Hankin, J.H.; Ross, R.K.; Yu, M.C. Cruciferous vegetables in relation to renal cell carcinoma. Int. J. Cancer 1998, 77, 211-216.
73. Smith, A.H.; Shearn, V.I.; Wood, R. Asbestos and kidney cancer: the evidence supports a causal association. Am. J. Ind. Med. 1989, 16 (2), 159-166.
74. Patel-Mandlik, K.J. Asbestos fibers in normal and cancerous human kidneys. Arch. Environ. Contam. Toxicol. 1981, 10 (1), 47-54.
75. Huang, J.; Hisanaga, N.; Sakai, K.; Iwata, M.; Ono, Y.; Shibata, E.; Takeuchi, Y. Asbestos fibers in human pulmonary and extrapulmonary tissues. Am. J. Ind. Med. 1988, 14 (3), 331-339.
76. Selikoff, I.J.; Hammond, E.C.; Seidman, H. Mortality experience of insulation workers in the United States and Canada, 1943-1976. Ann. N.Y. Acad. Sci. 1979, 330, 91-116.
77. Maclure, M. Asbestos and renal adenocarcinoma: a case-control study. Environ. Res. 1987, 42 (2), 353-361.
78. Enterline, P.E.; Hartley, J.; Henderson, V. Asbestos and cancer: a cohort followed up to death. Br. J. Ind. Med. 1987, 44 (6), 396-401.
79. Mandel, J.S.; McLaughlin, J.K.; Schlehofer, B.; Mellemgaard, A.; Helmert, U.; Lindblad, P.; McCredie, M.; Adami, H.O. International renal-cell cancer study. IV. Occupation. Int. J. Cancer 1995, 61 (5). 601-605.
80. Puntoni, R.; Vercelli, M.; Merlo, F.; Valerio, F.; Santi, L. Mortality among shipyard workers in Genoa, Italy. Ann. N.Y. Acad. Sci. 1979, 330, 353-377.
81. Parent, M.E.; Hua, Y.; Siemiatycki, I. Occupational risk factors for renal cell carcinoma in Montreal. Am. J. Ind. Med. 2000, 38 (6), 609-618.
82. Bond, G.G.; Shellenberger, R.J.; Flores, G.H.; Cook, R.R.; Fishbeck, W.A. A case-control study of renal cancer mortality at a Texas chemical plant. Am. J. Ind. Med. 1985, 7 (2), 123-139.
83. Saarni, H.; Pentti, J.; Pukkala, E. Cancer at sea: a case-control study among male Finnish seafarers. Occup. Environ. Med. 2002, 59 (9), 613-619.
84. Sali, D.; Boffetta, P. Kidney cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies. Cancer Causes Control 2000, 11 (1), 37-47.
85. Goodman, M.; Morgan, R.W.; Ray, R.; Malloy, C.D.; Zhao, K. Cancer in asbestos-exposed occupational cohorts: a meta-analysis. Cancer Causes Control 1999, 10 (5), 453-465.
86. Hu, J.; Mao, Y.; White, K. Renal cell carcinoma and occupational exposure to chemicals in Canada. Occup. Med. (Lond.) 2002, 52 (3), 157-164.
87. Partanen, T.; Heikkila, P.; Hernberg, S.; Kauppinen, T.; Moneta, G.; Ojajarvi, A. Renal cell cancer and occupational exposure to chemical agents. Scand. J. Work, Environ. & Health 1991, 17 (4), 231-239.
88. Pesch, B.; Haerting, J.; Ranft, U.; Klimpel, A.; Oelschlagel, B.; Schill, W. Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study. Int. J. Epidemiol. 2000, 29 (6), 1014-1024.
89. MacFarland, R.T.; Gandolfi, A.J.; Sipes, I.G. Extra-hepatic GSH-dependent metabolism of 1,2-dibromoethane (DBE) and 1,2-dibromo-3-chloropropane (DBCP) in the rat and mouse. Drug Chem. Toxicol. 1984, 7 (3), 213-227.
90. McLaughlin, J.K.; Blot, W.J.; Mehl, E.S.; Stewarl, P.A.; Venable, F.S.; Fraumeni, J.F., Jr. Petroleum-related employment and renal cell cancer. J. Occup. Med. 1985, 27 (9), 672-674.
91. Lynge, E.; Anttila, A.; Hemminki, K. Organic solvents and cancer. Cancer Causes Control 1997, 8 (3), 406-419.
92. Schnatter, A.R.; Katz, A.M.; Nicolich, M.J.; Theriault, G. A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ. Health Perspect. 1993, 101 (Suppl. 6), 85-99.
93. Siemiatycki, J.; Dewar, R.; Nadon, L.; Gerin, M.; Richardson, L.; Wacholder, S. Associations between several sites of cancer and twelve petroleum-derived liquids. Results from a case-reterent study in Montreal. Scand. J. Work, Environ. & Health 1987, 13 (6), 493-504.
94. Schlehofer, B.; Heuer, C.; Blettner, M.; Niehoff, D.; Wahrendorf, J. Occupation, smoking and demographic factors, and renal cell carcinoma in Germany. Int. J. Epidemiol. 1995, 24 (1), 51-57.
95. Sharpe, C.R.; Rochon, J.E.; Adam, J.M.; Suissa, S. Case-control study of hydrocarbon exposures in patients with renal cell carcinoma. CMAJ 1989, 140 (11), 1309-1318.
96. McLaughlin, J.K. Renal cell cancer and exposure to gasoline: a review. Environ. Health Perspect. 1993, 101 (Suppl. 6), 111-114.
97. Dement, J.M.; Hensley, L.; Gitelman, A. Carcinogenicity of gasoline: a review of epidemiological evidence, Ann. N.Y. Acad. Sci. 1997, 837, 53-76.
98. Brown, D.P.; Kaplan, S.D. Retrospective cohort mortality study of dry cleaner workers using perchloroethylene. J. Occup. Med. 1987, 29 (6), 535-541.
99. Blair, A.; Decoufle, P.; Grauman, D. Causes of death among laundry and dry cleaning workers. Am. J. Public Health 1979, 69 (5), 508-511.
100. Duh, R.W.; Asal, N.R. Mortality among laundry and-dry cleaning workers in Oklahoma. Am. J. Public Health 1984, 74 (11), 1278-1280.
101. Katz, R.M.; Jowett, D. Female laundry and dry cleaning workers in Wisconsin: a mortality analysis. Am. J. Public Health 1981, 71 (3), 305-307.
102. Lowery, J.T.; Peters, J.M.; Deapen, D.; London, S.J. Renal cell carcinoma among architects. Am. J. Ind. Med. 1991, 20 (1), 123-125.
103. Morgan, R.W.; Kelsh, M.A.; Zhao, K.; Heringer, S. Mortality of aerospace workers exposed to trichloroethylene. Epidemiology 1998, 9 (4), 424-431.
104. Blair, A.; Hartge, P.; Stewart, P.A.; McAdams, M.; Lubin, J. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: extended follow up. Occup. Environ. Med. 1998, 55 (3), 161-171.
105. Blair, A.; Stewart, P.A.; Tolbert, P.E.; Grauman, D.; Moran, F.X.; Vaught, J.; Rayner, J. Cancer and other causes of death among a cohort of dry cleaners. Br. J. Ind. Med. 1990, 47 (3), 162-168.
106. McLaughlin, J.K.; Blot, W.J. A critical review of epidemiology studies of trichloroethylene and perchloroethylene and risk of renal-cell cancer. Int. Arch. Occup. Environ. Health 1997, 70 (4), 222-231.
107. Blair, A.; Petralia, S.A.; Stewart, P.A. Extended mortality follow-up of a cohort of dry cleaners. Ann. Epidemiol. 2003, 13 (1), 50-56.
108. Wu, C.; Schaum, J. Exposure assessment of trichloroethylene. Environ. Health Perspect. 2000, 108 (Suppl. 2), 359-363.
109. Axelson, O.; Seiden, A.; Andersson, K.; Hogstedt, C. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J. Occup. Med. 1994, 36 (5), 556-562.
110. Spirtas, R.; Stewart, P.A.; Lee, J.S.; Marano, D.E.; Forbes, C.D.; Grauman, D.J.; Pettigrew, H.M.; Blair, A.; Hoover, R.N.; Cohen, J.L. Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. Br. J. Ind. Med. 1991, 48 (8), 515-530.
111. Anttila, A.; Pukkala, E.; Sallmen, M.; Hernberg, S.; Hemminki, K. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J. Occup. Environ. Med. 1995, 37 (7), 797-806.
112. Garabrant, D.H.; Held, J.; Langholz, B.; Bernstein, L. Mortality of aircraft manufacturing workers in southern California. Am. J. Ind. Med. 1988, 13 (6), 683-693.
113. Henschler, D.; Vamvakas, S.; Lammert, M.; Dekant, W.; Kraus, B.; Thomas, B.; Ulm, K. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethene. Arch. Toxicol. 1995, 69 (5), 291-299.
114. Vamvakas, S.; Bruning, T.; Thomasson, B.; Lammert, M.; Baumuller, A.; Bolt, H.M.; Dekant, W.; Birner, G.; Henschler, D.; Ulm, K. Renal cell cancer correlated with occupational exposure to trichloroethene. J. Cancer Res. Clin. Oncol. 1998, 124 (7), 374-382.
115. Mandel, J.S. Renal cell cancer correlated with occupational exposure to trichloroethylene. J. Cancer Res. Clin. Oncol. 2001, 127 (4), 265-268.
116. Bruning, T.; Pesch, B.; Wiesenhutter, B.; Rabstein, S.; Lammert, M.; Baumuller, A.; Bolt, H.M. Renal cell cancer risk and occupational exposure to trichloroethylene: results of a consecutive case-control study in Arnsberg, Germany. Am. J. Ind. Med. 2003, 43, 274-285.
117. Dosemeci, M.; Cocco, P.; Chow, W.H. Gender differences in risk of renal cell carcinoma and occupational exposures to chlorinated aliphatic hydrocarbons. Am. J. Ind. Med. 1999, 36 (1), 54-59.
118. Gomez, M.R.; Cocco, P.; Dosemeci, M.; Stewart, P.A. Occupational exposure to chlorinated aliphatic hydrocarbons: job exposure matrix. Am. J. Ind. Med. 1994, 26 (2), 171-183.
119. Ruder, A.M.; Ward, E.M.; Brown, D.P. Cancer mortality in female and male dry-cleaning workers. J. Occup. Med. 1994, 36 (8), 867-874.
120. Hansen, J.; Raaschou-Nielsen, O.; Christensen, J.M.; Johansen, I.; McLaughlin, J.K.; Lipworth, L.; Blot, W.J.; Olsen, J.H. Cancel-incidence among Danish workers exposed to trichloroethylene. J. Occup. Environ. Med. 2001, 43 (2), 133-139.
121. Brauch, H.; Weirich, G.; Hornauer, M.A.; Storkel, S.; Wohl, T.; Bruning, T. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J. Natl. Cancer Inst. 1999, 91 (10), 854-861.
122. Bruning, T.; Bolt, H.M. Renal toxicity and carcinogenicity of trichloroethylene: key results, mechanisms, and controversies. Crit. Rev. Toxicol. 2000, 30 (3), 253-285.
123. Dekant, W. Chemical-induced nephrotoxicity mediated by glutathione S-conjugate formation. Toxicol. Lett. 2001, 124 (1-3), 21-36.
124. Boffetta, P.; Dosemeci, M.; Gridley, G.; Bath, H.; Moradi, T.; Silverman, D. Occupational exposure to diesel engine emissions and risk of cancer in Swedish men and women. Cancer Causes Control 2001, 12 (4), 365-374.
125. Soll-Johanning, H.; Bach, E.; Olsen, J.H.; Tuchsen, F. Cancer incidence in urban bus drivers and tramway employees: a retrospective cohort study. Occup. Environ. Med. 1998, 55 (9), 594-598.
126. Redmond, C.K.; Ciocco, A.; Lloyd, J.W.; Rush, H.W. Long-term mortality study of steelworkers. VI. Mortality from malignant neoplasms among coke oven workers. J. Occup. Med. 1972, 14 (8), 621-629.
127. Redmond, C.K. Cancer mortality among coke oven workers. Environ. Health Perspect. 1983, 52, 67-73.
128. Costantino, J.P.; Redmond, CK.; Bearden, A. Occupationally related cancer risk among coke oven workers: 30 years of follow-up. J. Occup. Environ. Med. 1995, 37 (5), 597-604.
129. Bertazzi, P.A.; Pesatori, A.C.; Zocchetti, C.; Latocca, R. Mortality study of cancer risk among oil refinery workers. Int. Arch. Occup. Environ. Health 1989, 61 (4), 261-270.
130. Savitz, D.A.; Moure, R. Cancer risk among oil refinery workers. A review of epidemiologic studies. J. Occup. Med. 1984, 26 (9), 662-670.
131. Wong, O.; Harris, F.; Smith, T.J. Health effects of gasoline exposure. II. Mortality patterns of distribution workers in the United States. Environ. Health Perspect. 1993, 101 (Suppl. 6), 63-76.
132. Gamble, J.F.; Lewis, R.J.; Jorgensen, G. Mortality among three refinery/petrochemical plant cohorts. II. Retirees. J. Occup. Environ. Med. 2000, 42 (7), 730-736.
133. Wong, O.; Raabe, G.K. A critical review of cancer epidemiology in the petroleum industry, with a meta-analysis of a combined database of more than 350, 000 workers. Regul. Toxicol. Pharmacol. 2000, 32 (1), 78-98.
134. Pukkala, E. Cancer incidence among Finnish oil refinery workers, 1971-1994. J. Occup. Environ. Med. 1998, 40 (8), 675-679.
135. Poole, C.; Dreyer, N.A.; Satterfield, M.H.; Levin, L.; Rothman, K.J. Kidney cancer and hydrocarbon exposures among petroleum refinery workers. Environ. Health Perspect. 1993, 101 (Suppl. 6), 53-62.
136. Rushton, L. A 39-year follow-up of the U.K. oil refinery and distribution center studies: results for kidney cancer and leukemia. Environ. Health Perspect. 1993, 101 (Suppl. 6), 77-84.
137. Thomas, T.L.; Waxweiler, R.J.; Moure-Eraso, R.; Itaya, S.; Fraumeni, J.F., Jr. Mortality patterns among workers in three Texas oil refineries. J. Occup. Med. 1982, 24 (2), 135-141.
138. Ronneberg, A.; Langmark, F. Epidemiologic evidence of cancer in aluminum reduction plant workers. Am. J. Ind. Med. 1992, 22 (4), 573-590.
139. Ronneberg, A.; Andersen, A. Mortality and cancer morbidity in workers from an aluminium smelter with prebaked carbon anodes. Part II. Cancer morbidity. Occup. Environ. Med. 1995, 52 (4), 250-254.
140. Rockette, H.E.; Arena, V.C. Mortality studies of aluminum reduction plant workers: potroom and carbon department. J. Occup. Med. 1983, 25 (7), 549-557.
141. Boffetta, P.; Jourenkova, N.; Gustavsson, P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 1997, 8 (3), 444-472.
142. Mason, T.J. Geographic patterns of cancer risk: a means for identifying possible occupational factors. Ann. N.Y. Acad. Sci. 1976, 271, 370-376.
143. Lloyd, J.W.; Decoufle, P.; Salvin, L.G. Unusual mortality experience of printing pressmen. J. Occup. Med. 1977, 19 (8), 543-550.
144. Thomas, T.L.; Decoufle, P.; Moure-Eraso, R. Mortality among workers employed in petroleum refining and petrochemical plants. J. Occup. Med. 1980, 22 (2), 97-103.
145. Sinks, T.; Lushniak, B.; Haussler, B.J.; Sniezek, J.; Deng, J.F.; Roper, P.; Dill, P.; Coates, R. Renal cell cancer among paperboard printing workers. Epidemiology 1992, 3 (6), 483-489.
146. Paganini-Hill, A.; Glazer, E.; Henderson, B.E.; Ross, R.K. Cause-specific mortality among newspaper web pressmen. J. Occup. Med. 1980, 22 (8), 542-544.
147. Greene, M.H.; Hoover, R.N.; Eck, R.L.; Fraumeni, J.F., Jr. Cancer mortality among printing plant workers. Environ. Res. 1979, 20 (1), 66-73.
148. Auperin, A.; Benhamou, S.; Ory-Paoletti, C.; Flamant, R. Occupational risk factors for renal cell carcinoma: a case-control study. Occup. Environ. Med. 1994, 51 (6), 426-428.
149. Malker, H.R.; Malker, B.K.; McLaughlin, J.K.; Blot, W.J. Kidney cancer among leather workers. Lancet 1984, 1 (8367), 56.
150. Kolonel, L.N. Association of cadmium with renal cancer. Cancer 1976, 37 (4), 1782-1787.
151. Blinder, C.G.; Kjellstrom, T.; Hogstedt, C.; Andersson, K.; Spang, G. Cancer mortality of cadmium workers. Br. J. Ind. Med. 1985, 42 (10), 651-655.
152. Thun, M.J.; Schnorr, T.M.; Smith, A.B.; Halperin, W.E.; Lernen, R.A. Mortality among a cohort of U.S. cadmium production workers-an update. J. Natl. Cancer Inst. 1985, 74 (2), 325-333.
153. Lernen, R.A.; Lee, J.S.; Wagoner, J.K.; Blejer, H.P. Cancer mortality among cadmium production workers. Ann. N.Y. Acad. Sci. 1976, 271, 273-279.
154. Kjellstrom, T.; Friberg, L.; Rahnster, B. Mortality and cancer morbidity among cadmium-exposed workers. Environ. Health Perspect. 1979, 28, 199-204.
155. Silbergeld, E.K.; Waalkes, M.; Rice, J.M. Lead as a carcinogen: experimental evidence and mechanisms of action. Am. J. Ind. Med. 2000, 38 (3), 316-323.
156. Fowler, B.A.; Kahng, M.W.; Smith, D.R. Role of lead-binding proteins in renal cancer. Environ. Health Perspect. 1994, 102 (Suppl. 3), 115-116.
157. Steenland, K.; Boffetta, P. Lead and cancer in humans: where are we now? Am. J. Ind. Med. 2000, 38 (3), 295-299.
158. Steenland, K.; Selevan, S.; Landrigan, P. The mortality of lead smelter workers: an update. Am. J. Public Health 1992, 82 (12), 1641-1644.
159. Selevan, S.G.; Landrigan, P.J.; Stern, F.B.; Jones, J.H. Mortality of lead smelter workers. Am. J. Epidemiol. 1985, 122 (4), 673-683.
160. Cocco, P.; Hua, F.; Boffetta, P.; Carta, P.; Flore, C.; Flore, V.; Onnis, A.; Picchiri, G.F.; Colin, D. Mortality of Italian lead smelter workers. Scand. J. Work, Environ. & Health 1997, 23 (1), 15-23.
161. McLaughlin, J.K.; Malker, H.S.; Stone, B.J.; Weiner, J.A.; Malker, B.K.; Ericsson, J.L.; Blot, W.J.; Fraumeni, J.F., Jr. Occupational risks for renal cancer in Sweden. Br. J. Ind. Med. 1987, 44 (2), 119-123.
162. Simonato, L.; Fletcher, A.C.; Anderson, A.; Anderson, K.; Becker, N.; Chang-Claude, J.; Ferro, G.; Gerin, M.; Gray, C.N.; Hansen, K.S. A historical prospective study of European stainless steel, mild steel, and shipyard welders. Br. J. Ind. Med. 1991, 48 (3), 145-154.
163. Stern, F.B.; Sweeney, M.H.; Ward, E. Proportionate mortality among unionized construction ironworkers. Am. J. Ind. Med. 1997, 31 (2), 176-187.
164. Hemminki, K.; Jiang, Y.; Ma, X.; Yang, K.; Egevad, L.; Lindblad, P. Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors. Carcinogenesis 2002, 23 (5), 809-815.
165. Cooper, W.C.; Wong, O.; Kheifets, L. Mortality among employees of lead battery plants and lead-producing plants, 1947-1980. Scand. J. Work, Environ. & Health 1985, 11 (5), 331-345.
166. Sankila, R.; Karjalainen, S.; Laara, E.; Pukkala, E.; Teppo, L. Cancer risk among health care personnel in Finland, 1971-1980. Scand. J. Work, Environ. & Health 1990, 16 (4), 252-257.
167. Lerer, T.J.; Redmond, C.K.; Breslin, P.P.; Salvin, L.; Rush, H.W. Long-term mortality study of stellworkers. VII. Mortality patterns among crane operators. J. Occup. Med. 1974, 16 (9), 608-614.
168. Andersen, A.; Barlow, L.; Engeland, A.; Kjaerheim, K.; Lynge, E.; Pukkala, E. Work-related cancer in the Nordic countries. Scand. J. Work, Environ. & Health 1999, 25 (Suppl. 2), 1-116.
169. Mattos, I.E.; Sauaia, N.; Menezes, P.R. A cancer mortality patttern in Brazilian electrical workers. Cad. Saude Publica 2002, 18 (1), 221-233.
170. Shalat, S.L.; True, L.D.; Fleming, L.E.; Pace, P.E. Kidney cancer in utility workers exposed to polychlorinated biphenyls (PCBs). Br. J. Ind. Med. 1989, 46 (11), 823-824.
171. Milham, S., Jr. Cancer mortality pattern associated with exposure to metals. Ann. N.Y. Acad. Sci. 1976, 271, 243-249.
172. Delahunt, B.; Bethwaite, P.B.; Nacey, J.N. Occupational risk for renal cell carcinoma. A case-control study based on the New Zealand Cancer Registry. Br. J. Urol. 1995, 75 (5), 578-582.
173. Guidotti, T.L. Occupational mortality among firefighters: assessing the association. J. Occup. Environ. Med. 1995, 37 (12), 1348-1356.
174. Nicholas, J.S.; Lackland, D.T.; Dosemeci, M.; Mohr, L.C., Jr.; Dunbar, J.B.; Grosche, B.; Hoel, D.G. Mortality among US commercial pilots and navigators. J. Occup. Environ. Med. 1998, 40 (11), 980-985.
175. Band, P.R.; Le, N.D.; Fang, R.; Threlfall, W.J.; Astrakianakis, G.; Andersen, J.T.; Keefe, A.; Krewski, D. Cohort mortality study of pulp and paper mill workers in British Columbia, Canada. Am. J. Epidemiol. 1997, 146 (2), 186-194.
176. Mattioli, S.; Truffelli, D.; Baldasseroni, A.; Risi, A.; Marchesini, B.; Giacomini, C.; Bacchini, P.; Violante, F.S.; Buiatti, E. Occupational risk factors for renal cell cancer: a case-control study in northern Italy. J. Occup. Environ. Med. 2002, 44 (11), 1028-1036.
177. Bruning, T.; Chronz, C.; Thier, R.; Havelka, J.; Ko, Y.; Bolt, H.M. Occurrence of urinary tract tumors in miners highly exposed to dinitrotoluene. J. Occup. Environ. Med. 1999, 41 (3), 144-149.
178. Enterline, P.E.; Day, R.; Marsh, G.M. Cancers related to exposure to arsenic at a copper smelter. Occup. Environ. Med. 1995, 52 (1), 28-32.
179. Cantor, K.P.; Sontag, J.M.; Heid, M.F. Patteras of mortality among plumbers and pipefitters. Am. J. Ind. Med. 1986, 10 (1), 73-89.
180. Miller, B.A.; Blair, A.; Reed, E.J. Extended mortality follow-up among men and women in a U.S. furniture workers union. Am. J. Ind. Med. 1994, 25 (4), 537-549.
181. Buzio, L.; Tondel, M.; De Palma, G.; Buzio, C.; Franchini, J.; Mutti, A.; Axelson, O. Occupational risk factors for renal cell cancer. An Italian case-control study. Med. Lav. 2002, 93 (4), 303-309.
182. Cantor, K.P.; Hoover, R.; Mason, T.J.; McCabe, L.J. Associations of cancer mortality with halomethanes in drinking water. J. Natl. Cancer Inst. 1978, 61 (4), 979-985.
183. Wilkins, J.R., III; Comstock, G.W. Source of drinking water at home and site-specific cancer incidence in Washington County, Maryland. Am. J. Epidemiol. 1981, 114 (2), 178-190.
184. Yang, C.Y.; Chiu, H.F.; Cheng, M.F.; Tsai, S.S. Chlorination of drinking
185. Koivusalo, M.; Hakulinen, T.; Vartiainen, T.; Pukkala, E.; Jaakkola, J.J.; Tuomisto, J. Drinking water mutagenicity and urinary tract cancers: a population-based case-control study in Finland. Am. J. Epidemiol. 1998, 148 (7), 704-712.
186. Chen, C.J.; Chuang, Y.C.; Lin, T.M.; Wu, H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985, 45 (11 Pt 2), 5895-5899.
187. Wu, M.M.; Kuo, T.L.; Hwang, Y.H.; Chen, C.J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 1989, 130 (6), 1123-1132.
188. Chen, C.J.; Wang, C.J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 1990, 50 (17), 5470-5474.
189. Hopenhayn-Rich, C.; Biggs, M.L.; Smith, A.H. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 1998, 27 (4), 561-569.
190. Chiou, H.Y.; Chiou, S.T.; Hsu, Y.H.; Chou, Y.L.; Tseng, C.H.; Wei, M.L.; Chen, C.J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 2001, 153 (5), 411-418.
191. Kurttio, P.; Pukkala, E.; Kahelin, H.; Auvinen, A.; Pekkanen, J. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ. Health Perspect. 1999, 107 (9), 705-710.
192. Howe, H.L.; Wolfgang, P.E.; Burnett, W.S.; Nasca, P.C.; Youngblood, L. Cancer incidence following exposure to drinking water with asbestos leachate. Public Health Rep. 1989, 104 (3), 251-256.
193. Sadler, T.D.; Rom, W.N.; Lyon, J.L.; Mason, J.O. The use of asbestos-cement pipe for public water supply and the incidence of cancer in selected communities in Utah. J. Commun. Health 1984, 9 (4), 285-293.
194. Kanarek, M.S.; Conforti, P.M.; Jackson, L.A.; Cooper, R.C.; Murchio, J.C. Asbestos in drinking water and cancer incidence in the San Francisco Bay area. Am. J. Epidemiol. 1980, 112 (1), 54-72.
195. Graham, S.; Blanchet, M.; Rohrer, T. Cancer in asbestos-mining and other areas of Quebec. J. Natl. Cancer Inst. 1977, 59 (4), 1139-1145.
196. Cantor, K.P. Invited commentary: arsenic and cancer of the urinary tract. Am. J. Epidemiol. 2001, 153 (5), 422-423.
197. Phillips, J.L.; Pavlovich, C.P.; Walther, M.; Ried, T.; Linehan, W.M. The genetic basis of renal epithelial tumors: advances in research and its impact on prognosis and therapy. Curr. Opin. Urol. 2001, 11 (5), 463-469.
198. Latif, F.; Tory, K.; Gnarra, J.; Yao, M.; Duh, P.M.; Orcutt, M.L.; Stackhouse, T.; Kuzmin, I.; Modi, W.; Geil, L. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260 (5112), 1317-1320.
199. Pause, A.; Peterson, B.; Schaffar, G.; Stearman, R.; Klausner, R.D. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Proc. Natl. Acad. Sci. U. S. A. 1999, 96 (17), 9533-9538.
200. Hughson, M.D.; He, Z.; Liu, S.; Coleman, J.; Shingleton, W.B. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene. Cancer Genet. Cytogenet. 2003, 143, 145-153.
201. Pugh, C.W.; Ratcliffe, J. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factgor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 2003, 13, 83-89.
202. Sano, T.; Horiguchi, H. Von Hippel-Lindau disease. Microsc. Res. Tech. 2003, 60 (2), 159-164.
203. Hergovich, A.; Lisztwan, J.; Barry, R.; Ballschmieter, P.; Krek, W. Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat. Cell Biol. 2003, 5 (1), 64-70.
204. Gemmill, R.M.; West, J.D.; Boldog, F.; Tanaka, N.; Robinson, L.J.; Smith, D.I.; Li, F.; Drabkin, H.A. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc. Natl. Acad. Sci. U. S. A. 1998, 95 (16), 9572-9577.
205. Gallou, C.; Longuemaux, S.; Delomenie, C.; Mejean, A.; Martin, N.; Martinet, S.; Palais, G.; Bouvier, R.; Droz, D.; Krishnamoorthy, R.; Junien, C.; Beroud, C.; Dupret, J.M. Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma. Pharmacogenetics 2001, 11 (6), 521-535.
206. Ma, X.; Yang, K.; Lindblad, P.; Egevad, L.; Hemminki, K. VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium. Oncogene 2001, 20 (38), 5393-5400.
207. Foster, K.; Prowse, A.; van den, B.A.; Fleming, S.; Hulsbeek, M.M.; Crossey, P.A.; Richards, F.M.; Cairns, P.; Affara, N.A.; Ferguson-Smith, M.A. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.. Hum. Mol. Genet. 1994, 3 (12), 2169-2173.
208. Clifford, S.C.; Prowse, A.H.; Affara, N.A.; Buys, C.H.; Maher, E.R. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer 1998, 22 (3), 200-209.
209. Bruning, T.; Weirich, G.; Hornauer, M.A.; Hofler, H.; Brauch, H. Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene. Arch. Toxicol. 1997, 71 (5), 332-335.
210. Brauch, H.; Weirich, G.; Brieger, J.; Glavac, D.; Rodl, H.; Eichinger, M.; Feurer, M.; Weidt, E.; Puranakanitstha, C.; Neuhaus, C.; Pomer, S.; Brenner, W.; Schirmacher, P.; Storkel, S.; Rotter, M.; Masera, A.; Gugeler, N.; Decker, H.J. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Cancer Res. 2000, 60 (7), 1942-1948.
211. Fischer, J.; Palmedo, G.; von Knobloch, R.; Bugert, P.; Prayer-Galetti, T.; Pagano, F.; Kovacs, G. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours. Oncogene 1998, 17 (6), 733-739.
212. Johnson, M.; Koukoulis, G.; Matsumoto, K.; Nakamura, T.; Iyer, A. Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells. Hepatology 1993, 17 (6), 1052-1061.
213. Tomlinson, I.P.; Alam, N.A.; Rowan, A.J.; Barclay, E.; Jaeger, E.E.; Kelsell, D.; Leigh, I.; Gorman, P.; Lamlum, H.; Rahman, S.; Roylance, R.R.; Olpin, S.; Bevan, S.; Barker, K.; Hearle, N.; Houlston, R.S.; Kiuru, M.; Lehtonen, R.; Karhu, A.; Vilkki, S.; Laiho, P.; Eklund, C.; Vierimaa, O.; Aittomaki, K.; Hietala, M.; Sistonen, P.; Paetau, A.; Salovaara, R.; Herva, R.; Launonen, V.; Aaltonen, L.A. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 2002, 30 (4), 406-410.
214. Choyke, P.L.; Glenn, G.M.; Walther, M.M.; Zbar, B.; Linehan, W.M. Hereditary renal cancers. Radiology 2003, 226 (1), 33-46.
215. Nickerson, M.L.; Warren, M.B.; Toro, J.R.; Matrosova, V.; Glenn, G.; Turner, M.L.; Duray, P.; Merino, M.; Choyke, P.; Pavlovich, C.P.; Sharma, N.; Walther, M.; Munroe, D.; Hill, R.; Maher, E.; Greenberg, C.; Lerman, M.I.; Linehan, W.M.; Zbar, B.; Schmidt, L.S. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2002, 2 (2), 157-164.
216. Schulz, W.A.; Krummeck, A.; Rosinger, I.; Eickelmann, P.; Neuhaus, C.; Ebert, T.; Schmitz-Drager, B.J.; Sies, H. Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 1997, 7 (3), 235-239.
217. Sweeney, C.; Farrow, D.C.; Schwartz, S.M.; Eaton, D.L.; Checkoway, H.; Vaughan, T.L. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Cancer Epidemiol. Biomark. Prev. 2000, 9 (4), 449-454.
218. Bruning, T.; Lammert, M.; Kempkes, M.; Thier, R.; Golka, K.; Bolt, H.M. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch. Toxicol. 1997, 71 (9), 596-599.
219. Semenza, J.C.; Ziogas, A.; Largent, J.; Peel, D.; Anton-Culver, H. Gene-environment interactions in renal cell carcinoma. Am. J. Epidemiol. 2001, 153 (9), 851-859.
220. Longuemaux, S.; Delomenie, C.; Gallou, C.; Mejean, A.; Vincent-Viry, M.; Bouvier, R.; Droz, D.; Krishnamoorthy, R.; Galteau, M.M.; Junien, C.; Beroud, C.; Dupret, J.M. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res. 1999, 59 (12), 2903-2908.
221. Gago-Dominguez, M.; Castelao, J.E.; Yuan, J.-M.; Ross, R.K.; Yu, M.C. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 2002, 13, 287-293.
222. Mellemgaard, A.; McLaughlin, J.K.; Overvad, K.; Olsen, J.H. Dietary risk factors for renal cell carcinoma in Denmark. Eur. J. Cancer 1996, 32A (4), 673-682.
223. Bergstrom, A.; Terry, P.; Lindblad, P.; Lichtenstein, P.; Ahlbom, A.; Feychting, M.; Wolk, A. Physical activity and risk of renal cell cancer. Int. J. Cancer 2001, 92 (1), 155-157.
224. Lindblad, P.; Wolk, A.; Bergstrom, R.; Persson, I.; Adami, H.O. The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Cancer Epidemiol. Biomark. Prev. 1994, 3 (8), 631-639.
225. Bianchi, G.D.; Cerhan, J.R.; Parker, A.S.; Putnam, S.D.; See, W.A.; Lynch, C.F.; Cantor, K.P. Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. Am. J. Epidemiol. 2000, 151 (4), 377-383.
226. Chiu, B.C.; Lynch, C.F.; Cerhan, J.R.; Cantor, K.P. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Ann. Epidemiol. 2001, 11 (1), 28-37.
227. Parker, A.S.; Cerhan, J.R.; Lynch, C.F.; Ershow, A.C.; Cantor, K.P. Gender, alcohol consumption, and renal cell carcinoma. Am. J. Epidemiol. 2002, 155 (5), 455-462.
228. Gago-Dominguez, M.; Yuan, J.M.; Castelao, J.E.; Ross, R.K.; Yu, M.C. Family history and risk of renal cell carcinoma. Cancer Epidemiol. Biomark. Prev. 2001, 10 (9), 1001-1004.
229. Yuan, J.M.; Castelao, J.E.; Gago-Dominguez, M.; Ross, R.K.; Yu, M.C. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br. J. Cancer 1998, 77 (9), 1508-1513.
230. Yuan, J.M.; Gago-Dominguez, M.; Castelao, J.E.; Hankin, J.H.; Ross, R.K.; Yu, M.C. Cruciferous vegetables in relation to renal cell carcinoma. Int. J. Cancer 1998, 77 (2), 211-216.
231. Yuan, J.M.; Castelao, J.E.; Gago-Dominguez, M.; Yu, M.C.; Ross, R.K. Tobacco use in relation to renal cell carcinoma. Cancer Epidemiol. Biomark. Prev. 1998, 7 (5), 429-433.
232. Mellemgaard, A.; Lindblad, P.; Schlehofer, B.; Bergstrom, R.; Mandel, J.S.; McCredie, M.; McLaughlin, J.K.; Niwa, S.; Odaka, N.; Pommer, W. International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines. Int. J. Cancer 1995, 60 (3), 350-354.
233. Lindblad, P.; Mellemgaard, A.; Schlehofer, B.; Adami, H.O.; McCredie, M.; McLaughlin, J.K.; Mandel, J.S. International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int. J. Cancer 1995, 61 (2), 192-198.
234. Schlehofer, B.; Pommer, W.; Mellemgaard, A.; Stewart, J.H.; McCredie, M.; Niwa, S.; Lindblad, P.; Mandel, J.S.; McLaughlin, J.K.; Wahrendorf, J. International renal-cell cancer study. VI. The role of medical and family history. Int. J. Cancer 1996, 6 (6), 723-726.